Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News from in-PharmaTechnologis

01:08 EST 16th December 2018 | BioPortfolio

Here are the most relevant search results for "in-PharmaTechnologis" found in our extensive news archives from over 250 global news sources.

More Information about in-PharmaTechnologis on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about in-PharmaTechnologis for you to read. Along with our medical data and news we also list in-PharmaTechnologis Clinical Trials, which are updated daily. BioPortfolio also has a large database of in-PharmaTechnologis Companies for you to search.

Showing News Articles 1–25 of 415 from in-PharmaTechnologis

Thursday 13th December 2018

Indivior succeeds in putting Suboxone generic on hold again

Indiviorâs patent litigation with Dr. Reddyâs over Suboxone film continues after the company announced its preliminary injunction will stay in place.

US farm bill a boon for pharma?

If approved by President Trump, the five-year farm bill â which removes hemp from the federal controlled substance list â could help advance cannabinoid R&D, says Nexien Biopharma.

Is big pharma invested in small molecules? An ethical question

Large pharma has âa duty to societyâ to work in both the small and large molecule space, according to outgoing GSK executive, Dave Tudor.

Wednesday 12th December 2018

US FDA notes ‘disturbing lack of oversight’ over valsartan contamination

Zhejiang Huahai received a warning letter from the US FDA, which observed that it ignored two separate customer complaints about contamination.

Boehringer reshuffle cuts 327 jobs in France

Boehringer says it will reduce its workforce in France, including 182 positions in human health, to streamline operations in âdeteriorating marketsâ.

Funding provided by NIH to advance next-generation of antibiotics

Arrevus is awarded a $300,000 grant to develop a new class of compounds, utilizing a bacterial protein specific screening platform.

Tuesday 11th December 2018

Pfizer McPherson site hit with US FDA repeat observations

Pfizerâs sterile drug manufacturing site in Kansas received eight observations during an FDA inspection.

Fresenius Kabi wins US FDA award for relieving drug shortage

The FDA provided Fresenius Kabi helped with a Drug Shortage Assistance Award for providing IV saline solution during the Puerto Rico hurricane crisis.

A ‘no deal’ Brexit could affect UK-EU pharma trade for six months, says UK gov’t

Access to medicines across the English Channel could be âsignificantlyâ reduced for up to six months, if the UK leaves the EU without a deal, according to MP.

Monday 10th December 2018

US FDA slams Korean OTC maker: All employees ‘lack knowledge of GMP requirements’

The US regulator has issued Barox a warning letter citing labelling, storage and quarantine violations in Seongnam, South Korea.

Akorn CEO resigns after Fresenius merger collapses

The Supreme Court ruled that Fresenius was within its rights to terminate the merger agreement with Akorn.

Akorn appeal against Fresenius deal collapses, taking CEO with it

The Supreme Court ruled that Fresenius was within its rights to terminate the merger agreement with Akorn.

Sandoz’ EpiPen rival will launch in Q1, with lower price tag

Sandoz will launch its EpiPen generic in early 2019 at a lower price point than rival generics on the market.

Simpler drug delivery through capsule-based inhalation

Delivery by inhalation could be an easier way to deliver therapies in areas such as oncology, suggested ACGâs development manager.

Friday 7th December 2018

Hired and Retired: Year's end edition

As 2018 comes to a close, members of the industry are preparing to take on new roles for the upcoming year.

Thursday 6th December 2018

Takeda’s $62bn Shire acquisition is a go following shareholder votes

Takeda will takeover Shire, after shareholders approved the proposed acquisition, and is expected to close in early 2019.

Novo Nordisk pumps $22m into insulin manufacturing site

The Danish drugmaker has announced another investment at its diabetes finished products manufacturing facility in North Carolina, US.

US FDA notes 22 observations at Lupin’s Indian base

Lupin has received 22 observations across three facilities at its Mandideep campus, which the company says are only âprocedural in natureâ.

Wednesday 5th December 2018

Shouldering the responsibility: Male birth control absorbed through skin

A clinical trial has begun to test the safety and efficacy of male birth control in a drug delivered through application on the arms and shoulders.

Mylan expands valsartan recall in US

Mylan has requested all lots of valsartan, as well as combination amlodipine/valsartan, and valsartan/ hydrochlorothiazide tablets, be returned in the US.

US inspection protocols offer a more transparent, risk-based approach, says Recipharm

The US FDAâs New Inspection Protocol Project represents an âimprovement process stepâ towards a risk-based site selection model, according to the Swedish CDMO.

Tuesday 4th December 2018

GSK rebuilds oncology pipeline with $5.1bn acquisition

GSK entered an agreement with Tesaro to gain âunder-appreciatedâ PARP inhibitor assets and a Boston base.

Biovation invests in equipment able to create any tablet on the market

Biovation expands its technology portfolio with all-encompassing tableting equipment to grow its production capacity and change specifications âon the flyâ.

Unilever to acquire Horlicks and GSK’s Health Food Drinks portfolio

Unilever will acquire GlaxoSmithKlineâs Health Food Drinks portfolio in Asia for â3.3bn ($3.8bn): a move that will boost its presence in the Indian market.

Monday 3rd December 2018

Five further countries join EMA-FDA mutual recognition pact

Inspections of manufacturing facilities undertaken by Belgium, Denmark, Finland, Latvia and Estonia will be recognised as valid by the US FDA.


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks